Access Bio, Inc. (KOSDAQ: 950130)

Market Cap	204.22B
Revenue (ttm)	118.85B
Net Income (ttm)	-13.30B
Shares Out	33.81M
EPS (ttm)	-411.36
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	137,660
Average Volume	675,909
Open	6,050.00
Previous Close	6,040.00
Day's Range	5,860.00 - 6,050.00
52-Week Range	4,920.00 - 11,100.00
Beta	0.06
RSI	54.54
Earnings Date	Mar 17, 2025

About Access Bio

Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company provides Covid-19 detection kits, which are tests for assessing the current or past presence of SARS-CoV-2.; rapid diagnostic tests, suitable for preliminary diagnosis or emergency medical screening in medical facilities with limited resources; analyzers, designed to measure different chemicals and other characteristics in biological samples; and molecular diagnostic solu...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2002
• Employees: 101
• Stock Exchange: KOSDAQ
• Ticker Symbol: 950130